Search

Stephen Gucker

Examiner (ID: 445)

Most Active Art Unit
1649
Art Unit(s)
1649, 1647, 1812, 1818, 1646, 1645
Total Applications
799
Issued Applications
370
Pending Applications
114
Abandoned Applications
315

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3740269 [patent_doc_number] => 05753615 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Neuropeptides and their use as insecticides' [patent_app_type] => 1 [patent_app_number] => 8/522326 [patent_app_country] => US [patent_app_date] => 1995-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2849 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753615.pdf [firstpage_image] =>[orig_patent_app_number] => 522326 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/522326
Neuropeptides and their use as insecticides Oct 31, 1995 Issued
Array ( [id] => 4295666 [patent_doc_number] => 06184200 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Truncated glial cell line-derived neurotrophic factor' [patent_app_type] => 1 [patent_app_number] => 8/535681 [patent_app_country] => US [patent_app_date] => 1995-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 23005 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184200.pdf [firstpage_image] =>[orig_patent_app_number] => 535681 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/535681
Truncated glial cell line-derived neurotrophic factor Sep 27, 1995 Issued
Array ( [id] => 4323352 [patent_doc_number] => 06329158 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Use of dimly fluorescing nucleic acid dyes in the identification of nucleated cells' [patent_app_type] => 1 [patent_app_number] => 8/528828 [patent_app_country] => US [patent_app_date] => 1995-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 1627 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329158.pdf [firstpage_image] =>[orig_patent_app_number] => 528828 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/528828
Use of dimly fluorescing nucleic acid dyes in the identification of nucleated cells Sep 14, 1995 Issued
Array ( [id] => 3789657 [patent_doc_number] => 05840845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Senescent cell derived inhibitors of DNA synthesis' [patent_app_type] => 1 [patent_app_number] => 8/524218 [patent_app_country] => US [patent_app_date] => 1995-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 11776 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840845.pdf [firstpage_image] =>[orig_patent_app_number] => 524218 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/524218
Senescent cell derived inhibitors of DNA synthesis Sep 5, 1995 Issued
Array ( [id] => 1478489 [patent_doc_number] => 06451763 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Retinal pigmented epithelium derived neurotrophic factor and methods of use' [patent_app_type] => B1 [patent_app_number] => 08/520373 [patent_app_country] => US [patent_app_date] => 1995-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40192 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451763.pdf [firstpage_image] =>[orig_patent_app_number] => 08520373 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/520373
Retinal pigmented epithelium derived neurotrophic factor and methods of use Aug 28, 1995 Issued
Array ( [id] => 4333176 [patent_doc_number] => 06313265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Neurite outgrowth-promoting polypeptides containing fibronectin type III repeats and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/506296 [patent_app_country] => US [patent_app_date] => 1995-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 58 [patent_no_of_words] => 57821 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/313/06313265.pdf [firstpage_image] =>[orig_patent_app_number] => 506296 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/506296
Neurite outgrowth-promoting polypeptides containing fibronectin type III repeats and methods of use Jul 23, 1995 Issued
Array ( [id] => 4239423 [patent_doc_number] => 06080720 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Treatment method of bone and osteoblasts with neurotrophin-3 (NT-3)' [patent_app_type] => 1 [patent_app_number] => 8/505539 [patent_app_country] => US [patent_app_date] => 1995-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2810 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080720.pdf [firstpage_image] =>[orig_patent_app_number] => 505539 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/505539
Treatment method of bone and osteoblasts with neurotrophin-3 (NT-3) Jul 20, 1995 Issued
Array ( [id] => 4216945 [patent_doc_number] => 06087331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Therapeutic use of platelet-endothelial cell adhesion molecule-1 compositions' [patent_app_type] => 1 [patent_app_number] => 8/478208 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15743 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087331.pdf [firstpage_image] =>[orig_patent_app_number] => 478208 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/478208
Therapeutic use of platelet-endothelial cell adhesion molecule-1 compositions Jun 6, 1995 Issued
Array ( [id] => 693887 [patent_doc_number] => 07070782 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-04 [patent_title] => 'Prostate-specific membrane antigen' [patent_app_type] => utility [patent_app_number] => 08/481916 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 17 [patent_no_of_words] => 12810 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/070/07070782.pdf [firstpage_image] =>[orig_patent_app_number] => 08481916 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/481916
Prostate-specific membrane antigen Jun 6, 1995 Issued
08/487314 HUMAN CALCIUM SENSOR PROTEIN, FRAGMENTS THEREOF AND DNA ENCODING SAME Jun 6, 1995 Abandoned
Array ( [id] => 4410515 [patent_doc_number] => 06239270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Nucleic acids encoding human calcium sensor protein' [patent_app_type] => 1 [patent_app_number] => 8/476515 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 10 [patent_no_of_words] => 36790 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239270.pdf [firstpage_image] =>[orig_patent_app_number] => 476515 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/476515
Nucleic acids encoding human calcium sensor protein Jun 6, 1995 Issued
08/477298 PEPTIDE, IMMUNOGENIC COMPOSITIONS, VACCINES, AND MEDICINAL PREPARATIONS INCLUDING SAME; AND METHODS FOR IMMUNIZING A MAMMAL AGAINST LHRH, AND IMPROVING THE MEAT QUALITY OF PIGS Jun 6, 1995 Abandoned
Array ( [id] => 4270090 [patent_doc_number] => 06280732 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Methods of using an AL-1 neurotrophic factor immunoadhesin' [patent_app_type] => 1 [patent_app_number] => 8/486449 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23716 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/280/06280732.pdf [firstpage_image] =>[orig_patent_app_number] => 486449 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/486449
Methods of using an AL-1 neurotrophic factor immunoadhesin Jun 6, 1995 Issued
Array ( [id] => 1549781 [patent_doc_number] => 06399315 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Screening assays using cloned CRF receptors' [patent_app_type] => B1 [patent_app_number] => 08/482746 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27755 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399315.pdf [firstpage_image] =>[orig_patent_app_number] => 08482746 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/482746
Screening assays using cloned CRF receptors Jun 6, 1995 Issued
08/483139 CLONING AND RECOMBINANT PRODUCTION OF CRF RECEPTOR(S) Jun 6, 1995 Abandoned
08/486448 TGF-BETA TO IMPROVE NEURAL OUTCOME Jun 6, 1995 Abandoned
Array ( [id] => 3627478 [patent_doc_number] => 05621081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Glial mitogenic factors' [patent_app_type] => 1 [patent_app_number] => 8/471855 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 89 [patent_no_of_words] => 35444 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621081.pdf [firstpage_image] =>[orig_patent_app_number] => 471855 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/471855
Glial mitogenic factors Jun 5, 1995 Issued
Array ( [id] => 4355847 [patent_doc_number] => 06190880 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Recombinant bone morphogenetic protein heterodimers, compositions and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/469411 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 14 [patent_no_of_words] => 19519 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190880.pdf [firstpage_image] =>[orig_patent_app_number] => 469411 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/469411
Recombinant bone morphogenetic protein heterodimers, compositions and methods of use Jun 5, 1995 Issued
Array ( [id] => 4403486 [patent_doc_number] => 06270998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'DNA coding for human cell surface antigen' [patent_app_type] => 1 [patent_app_number] => 8/468560 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 13891 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/270/06270998.pdf [firstpage_image] =>[orig_patent_app_number] => 468560 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/468560
DNA coding for human cell surface antigen Jun 5, 1995 Issued
Array ( [id] => 408213 [patent_doc_number] => 07285531 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-23 [patent_title] => 'Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor' [patent_app_type] => utility [patent_app_number] => 08/472065 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 88 [patent_no_of_words] => 28039 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285531.pdf [firstpage_image] =>[orig_patent_app_number] => 08472065 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/472065
Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor Jun 5, 1995 Issued
Menu